Literature DB >> 8418197

The development of autoimmunity in C57BL/6 lpr mice correlates with the disappearance of natural killer type 1-positive cells: evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimmune symptoms.

K Takeda1, G Dennert.   

Abstract

F1 hybrid mice are able to acutely reject parental marrow grafts, a phenomenon that is due to natural killer type 1-positive (NK1+) cells. Circumstantial evidence had suggested that the antigenic determinants recognized by these cells are self-antigens, leading to the hypothesis that the physiological role of NK1+ cells is a downregulatory or suppressive function on bone marrow stem cell proliferation and lymphocyte function. In analyzing this hypothesis it is shown here that in young mice there is a temporal correlation between appearance of NK1+ cells in the spleen and the ability to reject allogeneic marrow or to suppress endogenous stem cell proliferation. The reverse situation exists in mice expressing the homozygous lpr gene. Whereas in young mice cells with NK1+ phenotype are demonstrable, these cells disappear with age, i.e., at the time autoimmunity develops. Concomitant with the disappearance of NK1+ cells, the ability to reject marrow grafts and to control endogenous stem cell proliferation also vanishes. The suggestion that the development of autoimmunity is causally related to the disappearance of NK1+ cells is supported by experiments in which NK1+ cells were either eliminated by antibody injection or increased by adoptively transferring cell populations enriched for NK1+ cells into lpr mice. It is shown that removal of cells enhances autoimmunity, whereas injection of NK1+ cells delays the onset of autoimmunity. In vitro assays are presented that demonstrate that suppression of autoantibody-secreting B cells is due to two NK1+ cell populations, one that expresses CD3 and causes specific suppression and one that lacks CD3 and causes nonspecific suppression.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8418197      PMCID: PMC2190856          DOI: 10.1084/jem.177.1.155

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  22 in total

1.  Early repair processes in marrow cells irradiated and proliferating in vivo.

Authors:  J E TILL; E A McCULLOCH
Journal:  Radiat Res       Date:  1963-01       Impact factor: 2.841

2.  Expression and function of the CD3-antigen receptor on murine CD4+8+ thymocytes.

Authors:  W L Havran; M Poenie; J Kimura; R Tsien; A Weiss; J P Allison
Journal:  Nature       Date:  1987 Nov 12-18       Impact factor: 49.962

3.  Detection of native and denatured DNA antibody forming cells by the enzyme-linked immunospot assay. A clinical study of (New Zealand black x New Zealand white)F1 mice.

Authors:  D G Ando; F M Ebling; B H Hahn
Journal:  Arthritis Rheum       Date:  1986-09

4.  Establishment of monoclonal anti-Nk-1.1 antibody.

Authors:  G C Koo; J R Peppard
Journal:  Hybridoma       Date:  1984

5.  Homeostasis of the antibody response: immunoregulation by NK cells.

Authors:  L V Abruzzo; D A Rowley
Journal:  Science       Date:  1983-11-11       Impact factor: 47.728

6.  Mouse lymphocytes with and without surface immunoglobulin: preparative scale separation in polystyrene tissue culture dishes coated with specifically purified anti-immunoglobulin.

Authors:  M G Mage; L L McHugh; T L Rothstein
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

7.  The NK-1.1(-) mouse: a model to study differentiation of murine NK cells.

Authors:  G C Koo; F J Dumont; M Tutt; J Hackett; V Kumar
Journal:  J Immunol       Date:  1986-12-15       Impact factor: 5.422

8.  Evidence for extrathymic development of TNK cells. NK1+ CD3+ cells responsible for acute marrow graft rejection are present in thymus-deficient mice.

Authors:  K Kikly; G Dennert
Journal:  J Immunol       Date:  1992-07-15       Impact factor: 5.422

9.  Mechanisms of T and B cell collaboration in the in vitro production of anti-DNA antibodies in the NZB/NZW F1 murine SLE model.

Authors:  D G Ando; E E Sercarz; B H Hahn
Journal:  J Immunol       Date:  1987-05-15       Impact factor: 5.422

10.  Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection.

Authors:  W J Murphy; V Kumar; M Bennett
Journal:  J Exp Med       Date:  1987-04-01       Impact factor: 14.307

View more
  52 in total

Review 1.  The cells that knew too much.

Authors:  A G Baxter
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

2.  Simultaneous activation of natural killer T cells and autoantibody production in mice injected with denatured syngeneic liver tissue.

Authors:  T Naito; T Kawamura; M Bannai; T Kosaka; H Kameyama; K Shimamura; O Hoshi; T Ushiki; K Hatakeyama; T Abo
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

Review 3.  Going both ways: immune regulation via CD1d-dependent NKT cells.

Authors:  Dale I Godfrey; Mitchell Kronenberg
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

4.  Innate immune natural killer cells and their role in HIV and SIV infection.

Authors:  Pavel Bostik; Yoshiaki Takahashi; Ann E Mayne; Aftab A Ansari
Journal:  HIV Ther       Date:  2010-07-01

5.  Disparate effects of depletion of CD1d-reactive T cells during early versus late stages of disease in a genetically susceptible model of lupus.

Authors:  J Jacinto; P J Kim; R R Singh
Journal:  Lupus       Date:  2011-11-07       Impact factor: 2.911

Review 6.  Immunologic states of autoimmune diseases.

Authors:  Toru Abo; Toshihiko Kawamura; Hisami Watanabe
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

7.  Intensive generation of NK1.1- extrathymic T cells in the liver by injection of bone marrow cells isolated from mice with a mutation of polymorphic major histocompatibility complex antigens.

Authors:  R C Halder; T Kawamura; M Bannai; H Watanabe; H Kawamura; M K Mannoor; S R Morshed; T Abo
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

Review 8.  The role of invariant natural killer T cells in lupus and atherogenesis.

Authors:  Amy S Major; Ram R Singh; Sebastian Joyce; Luc Van Kaer
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 9.  Role of T cells and dendritic cells in glomerular immunopathology.

Authors:  Christian Kurts; Felix Heymann; Veronika Lukacs-Kornek; Peter Boor; Jürgen Floege
Journal:  Semin Immunopathol       Date:  2007-10-23       Impact factor: 9.623

10.  Increased proportion of CD56bright natural killer cells in active and inactive systemic lupus erythematosus.

Authors:  Danika Schepis; Iva Gunnarsson; Maija-Leena Eloranta; Jon Lampa; Stefan H Jacobson; Klas Kärre; Louise Berg
Journal:  Immunology       Date:  2008-06-18       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.